27 results on '"Tricuspid valve function"'
Search Results
2. Editorial for 'Improved Tricuspid Valve Function, Preload Recruitment and Ventricular Efficiency During Submaximal Exercise in Patients With Unoperated Ebstein's Anomaly: An MRI Study'
- Author
-
Vibeke Hjortdal and Steffen Ringgaard
- Subjects
medicine.medical_specialty ,business.industry ,Heart Ventricles ,Submaximal exercise ,Heart Ventricles/diagnostic imaging ,Tricuspid valve function ,medicine.disease ,Magnetic Resonance Imaging ,Tricuspid Valve Insufficiency ,Ebstein Anomaly ,Preload ,Tricuspid Valve/diagnostic imaging ,Internal medicine ,Ebstein's anomaly ,medicine ,Cardiology ,Ebstein Anomaly/diagnostic imaging ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,Tricuspid Valve ,business - Published
- 2021
- Full Text
- View/download PDF
3. Surgical Algorithm for Rheumatic Tricuspid Disease
- Author
-
Alok Mathur, Piyush Mittal, Neeraj Sharma, and Pradeep Goyal
- Subjects
Pulmonary and Respiratory Medicine ,Aortic valve disease ,congenital, hereditary, and neonatal diseases and abnormalities ,Heart disease ,Tricuspid disease ,Regurgitation (circulation) ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,In patient ,cardiovascular diseases ,Cardiac Surgical Procedures ,TRICUSPID VALVE REPAIR ,Tricuspid valve ,business.industry ,Rheumatic Heart Disease ,medicine.disease ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,medicine.anatomical_structure ,030228 respiratory system ,cardiovascular system ,Surgery ,Tricuspid Valve ,Cardiology and Cardiovascular Medicine ,business ,Algorithm ,Algorithms - Abstract
Rheumatic involvement of the tricuspid valve frequently occurs in patients with mitral and aortic valve disease. Inadequate attention to tricuspid valve function can lead to increased morbidity and may necessitate reoperation. A surgical algorithm is developed and presented for treatment of rheumatic heart disease. Seventy-four patients underwent tricuspid valve repair. Competent tricuspid valve (not more than mild tricuspid regurgitation) could be achieved in all of these patients.
- Published
- 2019
- Full Text
- View/download PDF
4. A Novel Right Ventricular Volume and Pressure Loaded Piglet Heart Model for the Study of Tricuspid Valve Function
- Author
-
Richard B. Thompson, Lily Lin, James Y. Coe, Timothy Colen, Nee Scze Khoo, Ziad Abu Sara, Darren H. Freed, Sanaz Hatami, Walter Herzog, Consolato Sergi, and Elena S. Di Martino
- Subjects
Male ,medicine.medical_specialty ,Swine ,General Chemical Engineering ,medicine.medical_treatment ,Heart Ventricles ,Hemodynamics ,Intracardiac pressure ,Pulmonary Artery ,General Biochemistry, Genetics and Molecular Biology ,Imaging, Three-Dimensional ,medicine.artery ,Internal medicine ,medicine ,Pressure ,Animals ,Anesthesia ,Thoracotomy ,Pulmonary Valve ,Tricuspid valve ,General Immunology and Microbiology ,business.industry ,General Neuroscience ,Organ Size ,Tricuspid valve function ,medicine.anatomical_structure ,Echocardiography ,Pulmonary valve ,Pulmonary artery ,Models, Animal ,Cardiology ,Ventricular volume ,Female ,Tricuspid Valve ,business - Abstract
Heart conditions in which the tricuspid valve (TV) faces either increased volume or pressure stressors are associated with premature valve failure. Mechanistic studies to improve our understanding of the underlying pathophysiology responsible for the development of premature TV failure are lacking. Due to the inability to conduct these studies in humans, an animal model is required. In this manuscript, we describe the protocols for a novel chronic recovery infant piglet heart model for the study of changes in the TV when placed under combined volume and pressure stress. In this model, volume loading of the right ventricle and the TV is achieved through the disruption of the pulmonary valve. Then pressure loading is accomplished through the placement of a pulmonary artery band. The success of this model is assessed at four weeks post intervention surgery through echocardiography, intracardiac pressure measurement, and pathologic examination of the heart specimens.
- Published
- 2020
5. Assessment of Tricuspid Valve Detachment Efficiency for Ventricular Septal Defect Closure: A Retrospective Comparative Study
- Author
-
Bilen, Cagatay, Akkaya, Gokmen, Tuncer, Osman Nuri, Atay, Yuksel, and Ege Üniversitesi
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,Tricuspid valve detachment ,Tricuspid valve function ,Original Article ,cardiovascular diseases ,Ventricular septal defect - Abstract
BACKGROUND: The aim of this study was to investigate the efficiency of tricuspid valve detachment (TVD) during the surgical treatment of perimembranous ventricular septal defects (VSDs) and to compare the early and mid-term results to patients without TVD in terms of tricuspid insufficiency. METHODS: A total of 170 patients who had undergone surgical closure of perimembranous VSDs between November 2012 and January 2019 were included in this study, of whom 50 had an additional TVD procedure during the surgery. All patients were examined by transthoracic echocardiography before and after the operation with regular intervals, and the tricuspid valve function was then evaluated. RESULTS: There was no significant difference between subgroups with an unchanging degree of TVR, however, the result was also similar among those who had a decreased degree of TVR at any level (p = 0.271, p = 0.451). At the end of the study, all patients were in New York Heart Association class I. CONCLUSIONS: We suggest that, in appropriate patients, VSD closure can be safely performed with an additional TVD application through an incision of the septal leaflet of the tricuspid valve without impairing the valve function or reducing the growth potential of the valve at midterm follow-up.
- Published
- 2020
6. Evaluation of Tricuspid and Pulmonary Valves Using Epicardial and Transesophageal Echocardiography—A Comparative Study.
- Author
-
Kumbharathi, Ravi B., Taneja, Ravi, Mehra, Rishi, Quantz, Mackenzie A., Guo, Lin R., and Bainbridge, Daniel T.
- Subjects
TRANSESOPHAGEAL echocardiography ,TRICUSPID valve ,PULMONARY valve ,CORONARY artery bypass ,MEDICAL statistics ,COMPARATIVE studies ,PATIENTS - Abstract
Objective: To compare measurements obtained by transesophageal echocardiography (TEE) and epicardial echocardiography (EE) for evaluation of the tricuspid valve (TV) and pulmonary valve (PV). Design: Prospective observational. Setting: University hospital. Participants: Patients undergoing elective coronary artery bypass grafting with or without aortic valve replacement. Interventions: After routine intraoperative TEE, EE was performed to compare measurements obtained by the 2 methods. Measurements and main results: After institutional review board approval, 25 patients >18 years old were recruited. Biases with EE versus TEE for E and A waves were 11.9 cm/second (95% confidence interval [CI], 48.2 to −24.4) and 6.8 cm/second (95% CI, 28 to −15), respectively, and for E/A ratio was 0.08 (95% CI, 1.2 to −1). Pulmonary velocity bias was 57.94 cm/second (95% CI, 192.9 to −76.98), with higher values using EE. Bias for pulmonary trunk diameter was −0.31 cm (95% CI, 1.5 to −2.1). For quality of images, means were 2.4 (standard deviation [SD], 1.0) for EE and 2.3 (SD, 0.57) with TEE for TV and 2.4 (SD, 1.0) with EE and 2.5 (SD, 1.0) with TEE for PV. For the number of leaflets visualized, means were 2.2 (SD, 1.0) with EE and 2.5 (SD, 0.5) with TEE for TV and 2.5 (SD, 0.5) for EE and 1.3 (SD, 1.1) with TEE for PV. Conclusions: There was good agreement for Doppler measurements across TVs; however, measurements across PVs were significantly higher with EE versus TEE. TV Doppler measurements were difficult to acquire even for surgeons experienced in epiaortic scanning. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
7. Right ventricular and tricuspid valve function in patients chronically implanted with leadless pacemakers
- Author
-
Roch Giorgi, Jean-Claude Deharo, Jérôme Hourdain, Erwan Salaun, Linda Koutbi-Franceschi, Gilbert Habib, Frédéric Franceschi, Lilith Tovmassian, Blandine Simonnet, Hôpital de la Timone [CHU - APHM] (TIMONE), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Dysoxie, suractivité : aspects cellulaires et intégratifs thérapeutiques (DS-ACI / UMR MD2), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département de Cardiologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Timone [CHU - APHM] (TIMONE)-Assistance Publique - Hôpitaux de Marseille (APHM), Hôpital de la Timone [CHU - APHM] ( TIMONE ) -Assistance Publique - Hôpitaux de Marseille ( APHM ), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale ( SESSTIM - U912 INSERM - Aix Marseille Univ - IRD ), Institut de Recherche pour le Développement ( IRD ) -Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Dysoxie, suractivité : aspects cellulaires et intégratifs thérapeutiques ( DS-ACI / UMR MD2 ), Aix Marseille Université ( AMU ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Guieu, régis, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD), Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Centre recherche en CardioVasculaire et Nutrition (C2VN), and Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)
- Subjects
Male ,medicine.medical_specialty ,Cardiac pacing ,Heart Ventricles ,[SDV]Life Sciences [q-bio] ,Sinus bradycardia ,Regurgitation (circulation) ,030204 cardiovascular system & hematology ,law.invention ,Prosthesis Implantation ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,law ,Tricuspid valve ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Aged ,Aged, 80 and over ,[ SDV ] Life Sciences [q-bio] ,business.industry ,Cardiac Pacing, Artificial ,Atrial fibrillation ,Chronic implantation ,medicine.disease ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,3. Good health ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,Echocardiography ,cardiovascular system ,Cardiology ,Right ventricle ,Artificial cardiac pacemaker ,Female ,France ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Leadless cardiac pacemaker ,Follow-Up Studies - Abstract
Aims Leadless cardiac pacing has recently been proposed as alternative to conventional right ventricular (RV) pacing. With this approach, devices are directly screwed or fixed with tines in the RV wall, but the possible consequences on RV and tricuspid valve (TV) structure and function remain unknown. We thus conducted a study to evaluate this potential impact in chronically implanted patients. Methods and results Repeated echocardiographic studies were performed prior to implantation, at discharge, and 2 months thereafter on all consecutive patients implanted with a leadless pacemaker at our centre between October 2014 and end-December 2015. Whenever possible, patients were evaluated in non-paced rhythm. Anatomical and functional parameters of RV, TV, and left cardiac structures were assessed. Overall, 23 patients (12 females, aged 85.2 ± 6.3 years) were included, with 14 implanted using Nanostim™ (Saint Jude Medical) and 9 with Micra™ (Medtronic). Indications for pacing were paroxysmal atrio-ventricular block in 12 patients, intermittent sinus bradycardia in 5, unexplained syncope in 3, and atrial fibrillation with slow ventricular rate in the remaining 3. The pacing percentage was 34 ± 42% at the last visit. Most devices were implanted in the septo-apical or mid-septal region. There were no significant changes in echocardiographic parameters observed. One patient developed significantly increased TV regurgitation, without abnormal leaflet motion or TV annulus size changes, suggesting it to be due to RV pressure changes. Conclusion In patients chronically implanted with leadless pacemakers, there were no significant changes in heart structure and function observed, especially concerning the RV and TV.
- Published
- 2017
- Full Text
- View/download PDF
8. Percutaneous closure of symptomatic large tricuspid paravalvular regurgitation using two muscular VSD occluders
- Author
-
Aritra Mukherji, Rajaram Anantharaman, and Raghavan Subramanyan
- Subjects
Reoperation ,Cardiac Catheterization ,Leak ,medicine.medical_specialty ,Percutaneous ,RD1-811 ,Septal Occluder Device ,Heart block ,Muscular VSD occluder ,Case Report ,Regurgitation (circulation) ,Tricuspid regurgitation ,030204 cardiovascular system & hematology ,Prosthesis Design ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Internal medicine ,Valve replacement surgery ,medicine ,Humans ,Mitral Valve Stenosis ,Diseases of the circulatory (Cardiovascular) system ,Transcatheter closure ,030212 general & internal medicine ,cardiovascular diseases ,Cardiac Surgical Procedures ,Heart Valve Prosthesis Implantation ,business.industry ,Rare entity ,Middle Aged ,medicine.disease ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,Echocardiography, Doppler, Color ,Surgery ,Paravalvular leak ,Heart failure ,RC666-701 ,Cardiology ,cardiovascular system ,Female ,Cardiology and Cardiovascular Medicine ,business ,Echocardiography, Transesophageal ,Follow-Up Studies - Abstract
Paravalvular leaks are common following valve replacement surgery. Majority are benign and do not require any active intervention. However, occasionally severe paravalvular regurgitation can produce heart failure and/or hemolysis, needing closure of the defect. It is more commonly associated with aortic and mitral prosthesis, symptomatic tricuspid paravalvular regurgitation being a rare entity. In this report we present the successful percutaneous transcatheter closure of a large paravalvular tricuspid regurgitation in a 59-year old lady with history of multiple previous operations. The elongated crescent-shaped defect was closed using two muscular VSD devices without any residual leak and without hampering the bio-prosthetic tricuspid valve function. Patient had transient complete heart block during the procedure which recovered later. There was marked improvement in the symptomatic status of the patient at discharge (NYHA IV to NYHA II), which was sustained at follow-up.
- Published
- 2017
9. Tricuspid Valve: Congenital Abnormalities and Stenosis
- Author
-
Shelby Kutty and Pei-Ni Jone
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Tricuspid valve ,business.industry ,Valvular regurgitation ,medicine.disease ,Tricuspid valve function ,Tricuspid valve leaflet ,Stenosis ,medicine.anatomical_structure ,EBSTEIN ANOMALY ,Internal medicine ,Tricuspid valve stenosis ,cardiovascular system ,medicine ,Cardiology ,cardiovascular diseases ,business ,Surgical interventions - Abstract
Three-dimensional echocardiography (3DE) has incremental diagnostic value over two-dimensional echocardiography in the evaluation of the tricuspid valve. 3DE provides en face view of all leaflets of the tricuspid valve. The understanding of tricuspid valve leaflet morphology and mechanisms of valvular regurgitation from 3DE provides valuable insights into tricuspid valve function, and assists in the planning for surgical interventions. Congenital abnormalities of the tricuspid valve and illustrative clinical cases are presented in this chapter.
- Published
- 2019
- Full Text
- View/download PDF
10. Success of Tricuspid Valve Detachment for Ventricular Septal Defect Closure: An Assessment of Midterm Tricuspid Valve Function
- Author
-
Osman Nuri Tuncer, Yüksel Atay, Gökmen Akkaya, Çağatay Bilen, and Ege Üniversitesi
- Subjects
Mikrobiyoloji ,Tıbbi Laboratuar Teknolojisi ,Beslenme ve Diyetetik ,Nörolojik Bilimler ,Radyoloji, Nükleer Tıp, Tıbbi Görüntüleme ,Transplantasyon ,Medicine ,Anatomi ve Morfoloji ,Sağlık Bilimleri ve Hizmetleri ,Enfeksiyon Hastalıkları ,Patoloji ,Dermatoloji ,Cerrahi ,Beşeri Bilimler ,Tricuspid valve ,Odyoloji ve Konuşma-Dil Patolojisi ,Hücre Biyolojisi ,Ventricular septal defect,tricuspid valve detachment,congenital heart surgery ,Tıbbi İnformatik ,Tricuspid valve function ,Kadın Hastalıkları ve Doğum ,Onkoloji ,Periferik Damar Hastalıkları ,Psikiyatri ,medicine.anatomical_structure ,Tropik Tıp ,cardiovascular system ,Gastroenteroloji ve Hepatoloji ,Cardiology ,Romatoloji ,Biyoloji ,congenital, hereditary, and neonatal diseases and abnormalities ,Bilgi, Belge Yönetimi ,medicine.medical_specialty ,Temel Sağlık Hizmetleri ,Biyoteknoloji ve Uygulamalı Mikrobiyoloji ,Kalp ve Kalp Damar Sistemi ,Endokrinoloji ve Metabolizma ,Anestezi ,Bilim Felsefesi ve Tarihi ,Biyofizik ,Klinik Nöroloji ,Üroloji ve Nefroloji ,Defect closure ,Solunum Sistemi ,Internal medicine ,Spor Bilimleri ,Kulak, Burun, Boğaz ,Kadın Araştırmaları ,cardiovascular diseases ,Halk ve Çevre Sağlığı ,Geriatri ve Gerontoloji ,Genel ve Dahili Tıp ,Fizyoloji ,Göz Hastalıkları ,İmmünoloji ,business.industry ,Tıbbi Araştırmalar Deneysel ,Tıbbi Etik ,Pediatri ,Ortopedi ,Hematoloji ,Tamamlayıcı ve Entegre Tıp ,Rehabilitasyon ,Biyokimya ve Moleküler Biyoloji ,Yoğun Bakım, Tıp ,business - Abstract
Introduction: Ventricular septal defect (VSD) is the most common congenital heart anomaly. in surgical treatment, the transatrial approach is frequently utilized because of causing less right bundle block and ventricular scarring. However, some VSDs are obscured by the chordae tendineae or a pouch formation of the septal leaflet; therefore, alternative techniques are required. in such cases, tricuspid valve detachment (TVD) provides a complete visualization and ease to access to ventricular septal defects. in this study, we evaluated the results of the patients of whom we performed TVD. Patient and Method: Our study includes 50 patients who underwent TVD during the procedure with the diagnosis of perimembranous VSD. Patients were examined by transthoracic echocardiography (TTE) before and after operation and the valvular functions are evaluated. All patients were kept in follow up for 3 months after discharge. Results: the mean age of the patients was 27.56±34.81 months. At the end of the study, all patients were in New York Heart Association class I. There was no residual shunt through VSD. Except 4 patients with mild tricuspid regurgation (TR), the TTE has not revealed any TR in majority of patients. Conclusion: We suggest that, in appropriate patients, VSD closure can be performed safely with a TVD application thru an incision of the septal leaflet of the tricuspid valve without any adverse effect on function or growth at of the valve at midterm follow-up.
- Published
- 2019
- Full Text
- View/download PDF
11. In congenitally corrected transposition of great arteries following Fontan surgery, a left ventricle with suprasystemic systolic and high end-diastolic pressures paradoxically preserves right ventricular and tricuspid valve function
- Author
-
Kothandam Sivakumar, Ejaz Ahmed Sheriff, and Santosh Wadile
- Subjects
medicine.medical_specialty ,Heart Ventricles ,Diastole ,Blood Pressure ,030204 cardiovascular system & hematology ,Fontan Procedure ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,cardiovascular diseases ,Ventricular function ,business.industry ,General Medicine ,Tricuspid valve function ,Congenitally Corrected Transposition of the Great Arteries ,Surgery ,medicine.anatomical_structure ,Congenitally corrected transposition ,030228 respiratory system ,Ventricle ,Great arteries ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,cardiovascular system ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Systemic right ventricular function in congenitally corrected transposition depends on septal geometry. Suprasystemic left ventricular systolic pressures and high end-diastolic pressures after Fontan surgery paradoxically preserve right ventricular function.
- Published
- 2019
- Full Text
- View/download PDF
12. P5428Does right ventricular lead-placement for cardiac rhythm management effect tricuspid valve function? Insights from a single center Registry
- Author
-
E. Roczek, AG Lauten, Verena Tscholl, David M. Leistner, Patrick Nagel, Mattias Roser, M.O. Hoting, Alexander Lauten, and Charlotte Wewetzer
- Subjects
medicine.medical_specialty ,Rhythm ,Ventricular lead ,business.industry ,Internal medicine ,Cardiology ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,Tricuspid valve function ,Single Center - Published
- 2017
- Full Text
- View/download PDF
13. The Impact of Transvenous Lead Extraction on Tricuspid Valve Function
- Author
-
Avi Levine, James O. Coffey, Juan F. Viles-Gonzalez, Avi Fischer, Sandeep Gangireddy, and Solomon J. Sager
- Subjects
medicine.medical_specialty ,business.industry ,valvular heart disease ,General Medicine ,medicine.disease ,Single Center ,Tricuspid valve function ,Confidence interval ,Surgery ,Transvenous lead ,Patient age ,Internal medicine ,Cohort ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Lead extraction - Abstract
Background Few data exist regarding the effect of transvenous lead extraction (TLE) on tricuspid valve function. The objective of this study was to examine the effect of TLE on the development of postprocedure tricuspid regurgitation (TR). Objective To assess the impact of TLE on tricuspid valve function. Methods A single center retrospective analysis of consecutive patients referred for TLE between June 2006 and November 2011. Patients were included only if they underwent transthoracic echocardiography (TTE) before and after lead extraction (N = 124). Patients were assigned a preprocedure and postprocedure TR score on a continuous scale from 0 to 6 (0 = none, 1 = trace, 2 = mild, 3 = mild/moderate, 4 = moderate, 5 = moderate/severe, and 6 = severe). A clinically significant increase in TR was defined as both (1) an increase in TR score of at least two points, and (2) a postprocedure TR score ≥4 (moderate). Results A total of 124 patients referred for TLE underwent a TTE both before (9 ±16 months) and after lead extraction (4 ± 8 months). A total of 200 leads (1.6 ± 0.8 per patient) were extracted. The mean change in TR score after lead extraction was +0.18 (95% confidence interval [CI] −0.03 to 0.39, P = 0.11). A clinically significant increase in TR occurred in 7/124 (5.6% [CI 2.3–11.3%]) patients. Age ≥75 (+0.45, [CI 0.07–0.84, P = 0.02]), removal of ≥2 leads (+0.40 [CI 0–0.81, P = 0.05]), and powered sheath-assisted extraction (+0.34 [CI 0.05–0.62, P = 0.02]) were significantly associated with an increase in TR score. Conclusion TLE is rarely associated with the development of clinically significant TR. In our cohort, patient age ≥75 years, pacemaker as opposed to ICD, and removal of ≥2 leads predicted worsening TR.
- Published
- 2013
- Full Text
- View/download PDF
14. To the Editor
- Author
-
Laszlo Littmann, Sara Y. Narveson, and Nicole M. Fesel
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Internal medicine ,Icd lead ,medicine ,Cardiology ,General Medicine ,Cardiology and Cardiovascular Medicine ,Tricuspid valve function ,Implantable cardioverter-defibrillator ,business - Published
- 2012
- Full Text
- View/download PDF
15. Assessment of Tricuspid Valve Detachment Efficiency for Ventricular Septal Defect Closure: A Retrospective Comparative Study.
- Author
-
Bilen Ç, Akkaya G, Tuncer ON, and Atay Y
- Abstract
Background: The aim of this study was to investigate the efficiency of tricuspid valve detachment (TVD) during the surgical treatment of perimembranous ventricular septal defects (VSDs) and to compare the early and mid-term results to patients without TVD in terms of tricuspid insufficiency., Methods: A total of 170 patients who had undergone surgical closure of perimembranous VSDs between November 2012 and January 2019 were included in this study, of whom 50 had an additional TVD procedure during the surgery. All patients were examined by transthoracic echocardiography before and after the operation with regular intervals, and the tricuspid valve function was then evaluated., Results: There was no significant difference between subgroups with an unchanging degree of TVR, however, the result was also similar among those who had a decreased degree of TVR at any level (p = 0.271, p = 0.451). At the end of the study, all patients were in New York Heart Association class I., Conclusions: We suggest that, in appropriate patients, VSD closure can be safely performed with an additional TVD application through an incision of the septal leaflet of the tricuspid valve without impairing the valve function or reducing the growth potential of the valve at midterm follow-up.
- Published
- 2020
- Full Text
- View/download PDF
16. Correction of Traumatic Tricuspid Insufficiency Using the Double Orifice Technique
- Author
-
Li-Zhong Sun, Guohua Luo, Hansong Sun, Shengshou Hu, Jianping Xu, and Wei-Guo Ma
- Subjects
Adult ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Thoracic Injuries ,Regurgitation (circulation) ,Polypropylenes ,Wounds, Nonpenetrating ,medicine ,Humans ,Papillary muscle ,Rupture ,Cardiopulmonary Bypass ,Sutures ,business.industry ,Ring annuloplasty ,Suture Techniques ,General Medicine ,Middle Aged ,Papillary Muscles ,Surgical procedures ,Tricuspid insufficiency ,Tricuspid valve function ,medicine.disease ,Tricuspid Valve Insufficiency ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,Heart Valve Prosthesis ,cardiovascular system ,Chordae Tendineae ,Female ,Cardiology and Cardiovascular Medicine ,business ,Body orifice - Abstract
Traumatic tricuspid insufficiency is an uncommon clinical condition and surgical procedures vary. In this paper we report our experience in treating traumatic tricuspid insufficiency using the double orifice technique. From January 2000 to September 2003, 10 patients with traumatic tricuspid regurgitation were admitted to our hospital, 5 of whom were corrected using the double orifice technique. There were 4 males and 1 female with ages ranging from 31 to 52 years. Preoperative transthoracic echocardiography (TTE) detected severe tricuspid regurgitation in 4 patients and moderate tricuspid regurgitation in 1 patient. At surgery, tear of the tricuspid anterior papillary muscle was found in 2 cases and anterior chordal rupture in 3 cases. The valves were successfully repaired using the double orifice technique in combination with ring annuloplasty. There was no repeat operation, no operative complications or deaths. Before discharge, TTE detected normal tricuspid valve function in 2 cases and tiny regurgitation in 3 cases. After a follow up of 8 to 36 months, TTE demonstrated normal valve function in 1 patient and tiny regurgitation in 4 patients. The double orifice technique appears to be a simple but effective method of repairing traumatic tricuspid incompetence. Satisfactory clinical outcomes can be produced in carefully selected patients.
- Published
- 2005
- Full Text
- View/download PDF
17. A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography
- Author
-
Covadonga Fernández Golfin, José Luis Moya, Marcelo Haertel Miglioranza, José Luis Zamorano, Jose-Julio Jiménez-Nacher, and Derly Becker
- Subjects
medicine.medical_specialty ,Pacemaker, Artificial ,Echocardiography, Three-Dimensional ,Regurgitation (circulation) ,Simultaneous visualization ,Internal medicine ,medicine ,Tricuspid annulus ,Humans ,Radiology, Nuclear Medicine and imaging ,cardiovascular diseases ,Pacemaker complication ,Aged ,Tricuspid valve ,Cardiac cycle ,business.industry ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,Electrodes, Implanted ,medicine.anatomical_structure ,cardiovascular system ,Cardiology ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Complication - Abstract
Tricuspid regurgitation (TR) produced by endocavitary leads (EL) from permanent pacemakers and implantable cardiac defibrillators is a well-known complication of this procedure. The EL may damage or interfere with tricuspid valve function causing mechanical interference of the valve leaflets leading to incomplete valve closure. It is important to recognize this mechanical complication because it could be corrected by repositioning the lead. In this case report we demonstrate how three-dimensional transthoracic echocardiography permits to obtaining an en face view, which allows simultaneous visualization of the 3 moving leaflets during the cardiac cycle, their attachment to the tricuspid annulus and the pattern of leaflet coaptation. Thus, we propose three-dimensional transthoracic echocardiography as the tool of choice to evaluate TR related to EL, to evaluate the necessity of repositioning the lead if severe regurgitation or tricuspid valve malfunction are demonstrated.
- Published
- 2013
18. Bicaval versus atrial anastomoses in cardiac transplantation
- Author
-
A. Petry, E. G. Kraatz, Andres W. Jahnke, G. Herrmann, Rainer Leyh, Alexander Bernhard, HH Sievers, and Rüdiger Simon
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,business.industry ,Anastomosis ,Tricuspid insufficiency ,Control subjects ,Tricuspid valve function ,medicine.disease ,Right atrial ,Surgery ,Transplantation ,cardiovascular system ,Medicine ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,Prospective cohort study ,business ,Rest (music) - Abstract
Conventional cardiac transplantation with atrial anastomoses alters atrial integrity, geometry, and possibly function. Theoretically, this may also contribute to the development of tricuspid insufficiency that is frequently observed after the operation. Thus more anatomic transplantation techniques using bicaval anastomoses were recently introduced into clinical practice. Knowledge of their efficacy, however, is scarce. Therefore right atrial size and tricuspid valve function were compared in patients with bicaval (group A) and standard atrial (group B) anastomoses in a randomized, prospective study. The results of this echocardiographic study at rest and exercise in 18 patients (bicaval n = 8; atrial n = 10) on the average 28 months after transplantation are presented. The right atrial dimension was comparable between group A patients and control subjects and larger in group B patients ( p p
- Published
- 1994
- Full Text
- View/download PDF
19. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study
- Author
-
Itzhak Kronzon, Daniel M. Spevack, Larry A. Chinitz, John R. Bullinga, Paul A. Tunick, Harmony R. Reynolds, and Juyong Brian Kim
- Subjects
Male ,medicine.medical_specialty ,Pacemaker, Artificial ,medicine.medical_treatment ,New York ,Risk Assessment ,Prosthesis Implantation ,Risk Factors ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,Lead (electronics) ,Aged ,Ultrasonography ,business.industry ,Incidence ,Implantable cardioverter-defibrillator ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,Defibrillators, Implantable ,Electrodes, Implanted ,Treatment Outcome ,Cardiology ,Female ,Implant ,Permanent pacemaker ,Cardiology and Cardiovascular Medicine ,business ,Lead Placement - Abstract
This study assessed the effect of transtricuspid placement of permanent pacemaker (PPM) and implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation (TR) in 248 patients with echocardiograms before and after placement. Some 21.2% of patients with baseline mild TR or less developed abnormal TR (3.4% mild-moderate, 12.8% moderate, 1.1% moderate-severe, 3.9% severe) after implant. TR worsened by 1 grade or more after implant in 24.2% (20.7% of PPMs vs. 32.4% of ICDs; P < .05). TR worsening was more common with ICDs than PPMs in patients with baseline mild TR or less. After lead implantation, abnormal TR developed in 21.2% and severe TR developed in 3.9% of patients with initially normal TR. TR worsened by at least 1 grade in 24.2%. Patients with ICDs had a higher rate of TR worsening compared with patients with PPMs (32.4% vs. 20.1%; P < .05).
- Published
- 2007
20. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography
- Author
-
Judy Hung, Chaim Yosefy, Dali Fan, Lanqi Hua, David J. Dorer, Mark D. Handschumacher, Leng Jiang, Robert A. Levine, and Thanh Thao Ton-Nu
- Subjects
Heart Failure ,3 dimensional echocardiography ,Tricuspid valve ,Vena contracta ,business.industry ,Patient Selection ,Echocardiography, Three-Dimensional ,Arrhythmias, Cardiac ,Heart ,Anatomy ,Regurgitation (circulation) ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,medicine.anatomical_structure ,Functional tricuspid regurgitation ,Echocardiography ,Physiology (medical) ,medicine ,Image Processing, Computer-Assisted ,Humans ,In patient ,Heart Atria ,Cardiology and Cardiovascular Medicine ,business ,Tricuspid valve.annulus - Abstract
Background— Tricuspid regurgitation (TR) is an important predictor of morbidity and mortality in heart failure. We aimed to examine the 3D geometry of the tricuspid valve annulus (TVA) in patients with functional TR, comparing them with patients with normal tricuspid valve function and relating annular geometric changes to functional TR. Methods and Results— TVA shape was examined by real-time 3D echocardiography in 75 patients: 35 with functional TR and 40 with normal tricuspid valve function (referent group). The 3D shape of the TVA was reconstructed from rotated 2D planes, and the annular plane was computed by least-squares fitting. Annular area and mediolateral, anteroposterior, and high (superior)-low (inferior) distances were calculated. TR was assessed by vena contracta width. The normal TVA has a bimodal pattern (high-low distance=7.23±1.05 mm). High points were located anteroposteriorly, and low points were located mediolaterally. With moderate or greater TR (vena contracta width 5.80±2.62 mm), the TVA became dilated (17.24±4.75 versus 9.83±2.18 cm 2 , P P Conclusions— The normal TVA has a bimodal shape with distinct high points located anteroposteriorly and low points located mediolaterally. With functional TR, the annulus becomes larger, more planar, and circular. These changes in annular shape with TR have potentially important mechanistic and therapeutic implications for tricuspid valve repair.
- Published
- 2006
21. Right ventricular and tricuspid valve function in patients with two ventricular pacemaker leads
- Author
-
Cengiz Çeliker, Nuran Yazicioğlu, M. Serdar Küçükoğlu, Sinan Üner, and Alev Arat-Özkan
- Subjects
Male ,medicine.medical_specialty ,Pacemaker, Artificial ,Group ii ,Regurgitation (circulation) ,Internal medicine ,medicine ,Humans ,In patient ,cardiovascular diseases ,Lead (electronics) ,Aged ,business.industry ,Significant difference ,Middle Aged ,Tricuspid valve function ,Pacemaker leads ,Tricuspid Valve Insufficiency ,Surgery ,Ventricular pacemaker ,Echocardiography ,cardiovascular system ,Cardiology ,Ventricular Function, Right ,Female ,Tricuspid Valve ,Cardiology and Cardiovascular Medicine ,business - Abstract
Existing data on the effect of retained pacemaker leads on right ventricular (RV) and tricuspid valve function is limited. Objective: In this echocardiographic study we investigated the long-term effect of retained ventricular leads on RV and tricuspid valve function in patients with permanent pacemakers. Forty patients, 18 with two (group I) and 22 with one (group II) ventricular lead were assessed echocardiographically at an average of 39 months after the second lead implantation in group I and 80 months after the lead implantation in group II. The sum of the lead body diameter in group I was significantly greater than the body diameter in group II (P < 0.000). There was no significant difference between the groups with respect to chamber diameters and ventricular or valvular functions. The distributions of the different tricuspid regurgitation (TR) grades were similar, with the majority of patients in both groups having mild TR. Retained second pacemaker leads do not have an additional negative effect on right ventricular and tricuspid valve function.
- Published
- 2004
22. Concomitant repair of moderate tricuspid regurge in patients undergoing mitral valve surgery
- Author
-
Hany Mohamed, Islam M Ibrahim, Ahmed L Dokhan, and Yahia M Alkhateep
- Subjects
Surgical results ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Tricuspid valve ,business.industry ,Materials Science (miscellaneous) ,medicine.medical_treatment ,Mitral valve replacement ,Regurgitation (circulation) ,Tricuspid valve function ,Surgery ,medicine.anatomical_structure ,Internal medicine ,Concomitant ,cardiovascular system ,medicine ,Cardiology ,In patient ,cardiovascular diseases ,business ,Mitral valve surgery - Abstract
Objectives The aim of this study was to evaluate surgical results in patients with moderate tricuspid regurge undergoing mitral valve surgery either with or without concomitant tricuspid repair 6 months after surgery. Background Moderate tricuspid regurge has a variable natural history, as it may regress after mitral valve surgery without tricuspid repair, or may progress; hence, the decision to repair moderate tricuspid regurge in concomitant tricuspid repair with mitral valve surgery remains controversial. Patients and methods This study was conducted from January 2010 to June 2013. A total of 50 patients underwent mitral valve replacement for the first time with concomitant moderate tricuspid valve regurge. They were divided into two groups: group A (26 patients) who underwent mitral valve replacement alone, and group B (24 patients) who underwent mitral valve replacement and tricuspid valve repair using De Vega annuloplasty technique. Results The result showed that the tricuspid regurgitation improved postoperatively, irrespective of whether the repair was performed or not. However, statistical differences between group A and group B were significant. Conclusion Concomitant tricuspid valve repair with mitral valve surgery offered better early postoperative tricuspid valve function in patients with moderate tricuspid regurge, who underwent mitral valve surgery for chronic mitral valve disease.
- Published
- 2015
- Full Text
- View/download PDF
23. Pericardial patch augmentation of right atrioventricular valve in atrioventricular canal
- Author
-
Jacques A.M. van Son, Friedrich W. Mohr, and Volkmar Falk
- Subjects
Pulmonary and Respiratory Medicine ,Male ,Reoperation ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Time Factors ,Transplantation, Autologous ,Medium term ,Postoperative Complications ,Medicine ,Pericardium ,Humans ,cardiovascular diseases ,Child ,Atrioventricular valve ,Pericardial patch ,Tricuspid valve ,business.industry ,Tricuspid valve function ,humanities ,Tricuspid Valve Insufficiency ,Surgery ,medicine.anatomical_structure ,Echocardiography ,cardiovascular system ,Atrioventricular canal ,Tricuspid Valve ,Congenital disease ,Cardiology and Cardiovascular Medicine ,business ,Endocardial Cushion Defects ,Follow-Up Studies - Abstract
Untreated pericardial patch was successfully used to augment tissue-deficient bridging leaflets of the right atrioventricular valve in a patient after previous repair of complete common atrioventricular canal. Medium-term echocardiographic follow-up showed excellent tricuspid valve function with trivial central regurgitation.
- Published
- 1996
24. To the Editor
- Author
-
Sern Lim
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Icd lead ,Cardiac Resynchronization Therapy Devices ,MEDLINE ,General Medicine ,Tricuspid valve function ,Implantable cardioverter-defibrillator ,Internal medicine ,Cardiology ,medicine ,Cardiology and Cardiovascular Medicine ,business - Published
- 2012
- Full Text
- View/download PDF
25. Tricuspid regurgitation or Ebsteinoid dysplasia of the tricuspid valve in congenitally corrected transposition: Is valvuloplasty necessary at anatomic repair?
- Author
-
Patrick Olivier Myers, Victor Bautista-Hernandez, Pedro J. del Nido, Christopher W. Baird, Gerald R. Marx, and Sitaram M. Emani
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Balloon Valvuloplasty ,Male ,medicine.medical_specialty ,congenital, hereditary, and neonatal diseases and abnormalities ,Time Factors ,Adolescent ,Transposition of Great Vessels ,Regurgitation (circulation) ,Tricuspid valvuloplasty ,Young Adult ,Internal medicine ,Tricuspid Valve Insufficiency/diagnosis/etiology/physiopathology/surgery/therapy ,medicine ,Humans ,In patient ,Abnormalities, Multiple ,Transposition of Great Vessels/complications/diagnosis/surgery ,cardiovascular diseases ,Cardiac Surgical Procedures ,Child ,Retrospective Studies ,Tricuspid Valve/abnormalities/physiopathology/surgery ,Tricuspid valve ,Chi-Square Distribution ,ddc:617 ,business.industry ,Infant ,Recovery of Function ,medicine.disease ,Tricuspid valve function ,Tricuspid Valve Insufficiency ,Congenitally Corrected Transposition of the Great Arteries ,Surgery ,medicine.anatomical_structure ,Congenitally corrected transposition ,Treatment Outcome ,Dysplasia ,Great arteries ,Child, Preschool ,Cardiology ,cardiovascular system ,Female ,Tricuspid Valve ,Cardiology and Cardiovascular Medicine ,business - Abstract
ObjectivesPatients with congenitally corrected transposition of the great arteries can present with tricuspid regurgitation (TR) and Ebsteinoid dysplasia of the tricuspid valve. To determine the fate of the tricuspid valve after anatomic repair and the effectiveness of tricuspid valvuloplasty, we reviewed our experience with anatomic repair of congenitally corrected transposition of the great arteries.MethodsFrom 1992 to 2012, 106 patients with congenitally corrected transposition of the great arteries underwent anatomic repair. Of the 106 patients, 24 (22.6%) had moderate or greater TR before anatomic repair, 14 of whom had Ebsteinoid dysplasia. Nine patients (8.5%) had Ebsteinoid dysplasia without significant TR, and 73 patients (68.9%) had neither TR nor dysplasia.ResultsOf the 106 patients, 6 (5.6%) with TR underwent tricuspid valvuloplasty at anatomic repair, 5 with (21%) and 1 without (11%) Ebsteinoid dysplasia (P
- Full Text
- View/download PDF
26. Special considerations in ventricular pacing in patients with tricuspid valve disease
- Author
-
Myles Edwin Lee
- Subjects
Pulmonary and Respiratory Medicine ,Reoperation ,medicine.medical_specialty ,Heart Ventricles ,Tricuspid valve replacement ,Internal medicine ,medicine ,Humans ,In patient ,cardiovascular diseases ,Bioprosthesis ,Coronary Vein ,business.industry ,Cardiac Pacing, Artificial ,Ventricular pacing ,Pericardial space ,Middle Aged ,Tricuspid valve function ,Tricuspid valve disease ,Tricuspid Valve Insufficiency ,Surgery ,Heart Valve Prosthesis ,cardiovascular system ,Cardiology ,Female ,Tricuspid Valve ,Cardiology and Cardiovascular Medicine ,Lead Placement ,business - Abstract
In patients who have undergone prosthetic tricuspid valve replacement or tricuspid an-nuloplasty and in whom the pericardial space is obliterated by adhesions from previous operations, the need for ventricular pacing may be met by lead placement in the venous tributaries of the coronary veins. This approach avoids compromise of prosthetic tricuspid valve function and injury to biopros-thetic valves and natural valves repaired by annulo-plasty. Although acute stimulation thresholds are slightly higher than those for short-term endocardial implants, stable long-term ventricular pacing has been observed in patients reported in the literature in whom such lead placement was inadvertent and in the 2 patients in the present paper in whom such replacement was deliberate. This method appears to be a safe alternative to standard ventricular pacing techniques under the special circumstances reported here.
- Published
- 1983
27. EFFECT OF PATENT FORAMEN OVALE CLOSURE DEVICE ON AORTIC AND TRICUSPID VALVE FUNCTION
- Author
-
Roberto Corti, Christiane Gruner, Thomas F. Lüscher, Matthias Greutmann, Patrick T. Siegrist, and Nazmi Krasniqi
- Subjects
medicine.medical_specialty ,business.industry ,Patent foramen ovale ,Closure (topology) ,Medicine ,business ,medicine.disease ,Tricuspid valve function ,Cardiology and Cardiovascular Medicine ,Surgery - Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.